Christopher & Banks Corp. (NYSE:CBK) was up 8% during trading on Friday . The stock traded as high as $2.06 and last traded at $2.03, with a volume of 300,014 shares. The stock had previously closed at $1.88.

Several equities research analysts recently commented on CBK shares. Dougherty & Co raised shares of Christopher & Banks Corp. from a “neutral” rating to a “buy” rating and set a $3.25 price target for the company in a report on Thursday, April 7th. Zacks Investment Research cut shares of Christopher & Banks Corp. from a “hold” rating to a “strong sell” rating in a research note on Friday, April 8th. Finally, TheStreet cut shares of Christopher & Banks Corp. from a “hold” rating to a “sell” rating in a research note on Monday, April 11th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $4.00.

The stock has a 50 day moving average of $2.16 and a 200 day moving average of $2.08. The firm’s market cap is $75.28 million.

An institutional investor recently bought a new position in Christopher & Banks Corp. stock. Paradigm Capital Management Inc. NY purchased a new stake in Christopher & Banks Corp. (NYSE:CBK) during the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 638,807 shares of the company’s stock, valued at approximately $1,054,000. Paradigm Capital Management Inc. NY owned about 1.72% of Christopher & Banks Corp. as of its most recent SEC filing.

Christopher & Banks Corporation is a national specialty retailer featuring private-brand women’s apparel and accessories. The Company offers its customers an assortment of clothing for everyday needs. Its merchandise assortments include designs of women’s apparel, generally consisting of casual clothing, everyday basics, wear-to-work, leisure/active wear, and sleepwear in missy, petite and women sizes.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.